Mitesh

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 4 November 2023) has been published and includes articles on: Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir E-cigarette use or vaping: reminder [...]

The post MHRA Drug Safety Update: November 2023 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 250mg/5ml oral suspension are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP054 Clarithromycin 250mg/5ml oral suspension at 23.59pm on Friday 17 November 2023. After this date, any prescriptions for Clarithromycin 250mg/5ml oral suspension must be [...]

The post Expiry of SSP054 Clarithromycin 250mg/5ml oral suspension appeared first on Community Pharmacy England.

Updated 12th February 2024 – updates are shown in bold below: Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension  MSN/2023/103U Tier 3 – high impact  Date of issue 17th November 2023 (updated 12th February 2024) Co-trimoxazole 40mg/200mg/5ml oral [...]

The post Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension – Updated appeared first on Community Pharmacy England.

From 1 November 2023, the list of medicines covered by the HRT prepayment certificate (HRT PPC) will be updated to include a new brand of progesterone micronised capsules, Gepretix®. Part XVI of the November 2023 Drug Tariff will be updated to include the following new HRT medicine for which patients will be able to purchase an [...]

The post Gepretix® added to the HRT PPC medicines list from November 2023 appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 3 October 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age MedSafetyWeek November 2023: your Yellow Card report helps [...]

The post MHRA Drug Safety Update: October 2023 appeared first on Community Pharmacy England.